Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nisar

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
Clinical Rheumatology|January 9, 2013
What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidenceMuhammad K Nisar, Falak Masood, Paul Cookson, et al.
International Journal of Rheumatic Diseases|January 17, 2012
Musculoskeletal examination and junior doctors: cause for concern?Muhammad K Nisar, Belal El-Essawy, Anoop V Kuttikat, et al.
Clinical and Experimental Rheumatology|October 10, 2012
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature reviewNatalie Zhang, Sarah Wilkinson, Mehmood Riaz, et al.
BJC Reports|November 8, 2024
Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world?Anem Mirza, Zeyar Win Naing, Parisa Khonsari, et al.
Rheumatology (Oxford, England)|December 14, 2011
Non-infectious pulmonary toxicity of rituximab: a systematic reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Helen Parfrey, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
Clinical Rheumatology|June 19, 2026
The effect of biologic disease modifying anti-rheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patientsMartin Lauran, Chelsea Kyeremateng, Afrida Haque, et al.
Rheumatology (Oxford, England)|October 25, 2011
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Shweta Bhagat, et al.
Advances in Therapy|December 5, 2025
Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UKMatthew Tucker, Johannes Pöhlmann, Kristin Grabe-Heyne, et al.
Current Medical Research and Opinion|June 18, 2025
Real-world clinical outcomes of patients with moderate-to-severe rheumatoid arthritis initiating upadacitinib in the United Kingdom: final analysis from a prospective observational cohort study (ENDEAVOUR)James Taylor, Srinivasan Srirangan, Marwan Bukhari, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
Clinical Rheumatology|January 9, 2013
What do we know about juvenile idiopathic arthritis and vitamin D? A systematic literature review and meta-analysis of current evidenceMuhammad K Nisar, Falak Masood, Paul Cookson, et al.
International Journal of Rheumatic Diseases|January 17, 2012
Musculoskeletal examination and junior doctors: cause for concern?Muhammad K Nisar, Belal El-Essawy, Anoop V Kuttikat, et al.
Clinical and Experimental Rheumatology|October 10, 2012
Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis? A systematic literature reviewNatalie Zhang, Sarah Wilkinson, Mehmood Riaz, et al.
BJC Reports|November 8, 2024
Aromatase inhibitors and fracture prevention - do 2017 guidelines work in real world?Anem Mirza, Zeyar Win Naing, Parisa Khonsari, et al.
Rheumatology (Oxford, England)|December 14, 2011
Non-infectious pulmonary toxicity of rituximab: a systematic reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Helen Parfrey, et al.
BMC Medicine|February 14, 2023
Approaches to optimising access to NICE-approved biologic anti-TNFs for patients with rheumatoid arthritis with moderately active diseasePeter C Taylor, Ayman Askari, Ernest Choy, et al.
Clinical Rheumatology|June 19, 2026
The effect of biologic disease modifying anti-rheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patientsMartin Lauran, Chelsea Kyeremateng, Afrida Haque, et al.
Rheumatology (Oxford, England)|October 25, 2011
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature reviewAndreas V Hadjinicolaou, Muhammad K Nisar, Shweta Bhagat, et al.
Advances in Therapy|December 5, 2025
Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UKMatthew Tucker, Johannes Pöhlmann, Kristin Grabe-Heyne, et al.
Current Medical Research and Opinion|June 18, 2025
Real-world clinical outcomes of patients with moderate-to-severe rheumatoid arthritis initiating upadacitinib in the United Kingdom: final analysis from a prospective observational cohort study (ENDEAVOUR)James Taylor, Srinivasan Srirangan, Marwan Bukhari, et al.
Pageof 11